Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDKN1A | P38936 | 1/20 | 0.67 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.53 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.51 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.51 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.51 |
| ▸ | PIM1 | P11309 | 4/20 | 0.42 |
| ▸ | MAPK13 | O15264 | 2/20 | 0.42 |
| ▸ | GSK3A | P49840 | 3/20 | 0.42 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.42 |
| ▸ | AKT1 | P31749 | 1/20 | 0.42 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.42 |
| ▸ | BTK | Q06187 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.40 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.40 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.40 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.40 |
| ▸ | BRAF | P15056 | 1/20 | 0.40 |
| ▸ | CDK1 | P06493 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5810516 | 0.99 | CDKN1A (0.66) | CDKN1ATLR8MAP2K1CLK4DYRK1B | |
| SCHEMBL5823666 | 0.98 | CDKN1A (0.67) | CDKN1ATLR8MAP2K1CLK4DYRK1B | |
| SCHEMBL5807609 | 0.88 | CDKN1A (0.67) | CDKN1ATLR8MAP2K1CLK4DYRK1B | |
| SCHEMBL5821447 | 0.88 | CDKN1A (0.67) | CDKN1ATLR8MAP2K1CLK4DYRK1B | |
| SCHEMBL5823332 | 0.88 | CDKN1A (0.67) | CDKN1ATLR8MAP2K1CLK4DYRK1B | |
| SCHEMBL5946519 | 0.87 | CDKN1A (0.62) | CDKN1ATLR8MAP2K1CLK4DYRK1B | |
| SCHEMBL5808667 | 0.87 | CDKN1A (0.66) | CDKN1ATLR8MAP2K1CLK4DYRK1B | |
| SCHEMBL5807779 | 0.86 | CDKN1A (0.60) | CDKN1ATLR8MAP2K1CLK4DYRK1B | |
| SCHEMBL5808941 | 0.86 | CDKN1A (0.65) | CDKN1ATLR8MAP2K1CLK4DYRK1B | |
| SCHEMBL6071254 | 0.85 | TLR8 (0.53) | CDKN1ATLR8MAP2K1CLK4DYRK1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120028045-A1 | Processes for the Preparation of Indiplon and Intermediates Thereof | GLENMARK GENERICS LTD (IN) | 2012-02-02 | — | — | US | disclosed |
| US-20120028045-A1 | Processes for the Preparation of Indiplon and Intermediates Thereof | GLENMARK GENERICS LTD (IN) | 2012-02-02 | — | — | US | disclosed |
| WO-2010109480-A2 | PROCESSES FOR THE PREPARATION OF INDIPLON AND INTERMEDIATES THEREOF | GLENMARK GENERICS LIMITED (IN) | 2010-09-30 | — | — | WO | disclosed |
| WO-2006033795-A2 | SUBSTITUTED PYRAZOLO [1, 5-A] PYRIMIDINES FOR INHIBITING ABNORMAL CELL GROWTH | WYETH (US) | 2006-03-30 | — | — | WO | disclosed |
| WO-2006033796-A1 | SUBSTITUTED PYRAZOLO [1,5-a] PYRIMIDINES AND PROCESS FOR MAKING SAME | WYETH (US) | 2006-03-30 | — | — | WO | disclosed |
| US-20060063784-A1 | Method of using substituted pyrazolo [1,5-a] pyrimidines | WYETH | 2006-03-23 | — | — | US | disclosed |
| US-20060063785-A1 | Substituted pyrazolo[1,5-a] pyrimidines and process for making same | WYETH | 2006-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120028045-A1 | Processes for the Preparation of Indiplon and Intermediates Thereof | CYP2D6, HLA-B, HLA-DRB1 | CDKN1A 1289/4885TLR8 3517/4885MAP2K1 4776/4885 |
| US-20060063785-A1 | Substituted pyrazolo[1,5-a] pyrimidines and process for making same | TYMP, DPYD, TYMS | CDKN1A 28/4885TLR8 4399/4885MAP2K1 699/4885 |
| US-20060063784-A1 | Method of using substituted pyrazolo [1,5-a] pyrimidines | TYMP, DPYD, TYMS | CDKN1A 89/4885TLR8 4409/4885MAP2K1 528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.